Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133).
J Clin Oncol
; 39(6): 619-630, 2021 02 20.
Article
in En
| MEDLINE
| ID: mdl-33439693
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Carboplatin
/
Etoposide
/
Small Cell Lung Carcinoma
/
Antibodies, Monoclonal, Humanized
/
B7-H1 Antigen
/
Lung Neoplasms
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
2021
Document type:
Article
Country of publication: